Literature DB >> 2828299

Derivatives of oxetanocin: oxetanocins H, X and G, and 2-aminooxetanocin A.

N Shimada1, S Hasegawa, S Saito, T Nishikiori, A Fujii, T Takita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2828299     DOI： 10.7164/antibiotics.40.1788

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  4 in total

1.  Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds.

Authors:  J Seki; N Shimada; K Takahashi; T Takita; T Takeuchi; H Hoshino
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.

Authors:  Y Nishiyama; N Yamamoto; K Takahash; N Shimada
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

3.  Antiviral activity of oxetanocins against varicella-zoster virus.

Authors:  T Sakuma; M Saijo; T Suzutani; I Yoshida; S Saito; M Kitagawa; S Hasegawa; M Azuma
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model.

Authors:  T Nagahata; K Araki; K Yamamura; K Matsubara
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.